Literature DB >> 736022

Arterial thrombosis in ulcerative colitis.

D Braverman, A Bogoch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 736022     DOI： 10.1007/bf01072894

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN： 0002-9211


× No keyword cloud information.
  14 in total

1.  [Arterial thrombosis in ulcerative colitis].

Authors:  K Solheim; S Birkeland
Journal:  Tidsskr Nor Laegeforen       Date:  1975-10-30

2.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

3.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

4.  Surgical measures as supplements to the management of idiopathic ulcerative colitis; cancer, cirrhosis, and arthritis as frequent complications.

Authors:  C DENNIS; K E KARLSON
Journal:  Surgery       Date:  1952-11       Impact factor: 3.982

5.  Pathogenesis of ulcerative colitis.

Authors:  S WARREN; S C SOMMERS
Journal:  Am J Pathol       Date:  1949-07       Impact factor: 4.307

6.  Life histories of patients with chronic ulcerative colitis: a review of 2,000 cases.

Authors:  W P SLOAN; J A BARGEN; R P GAGE
Journal:  Gastroenterology       Date:  1950-09       Impact factor: 22.682

7.  Cerebral venous thrombosis as a complication of ulcerative colitis.

Authors:  M J Harrison; S C Truelove
Journal:  Am J Dig Dis       Date:  1967-10

8.  Thrombocytosis in ulcerative colitis and Crohn's disease.

Authors:  I Talstad; K Rootwelt; E Gjone
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

9.  Cerebrovascular occlusions in relatively young patients with regional enteritis.

Authors:  A Silverstein; D H Present
Journal:  JAMA       Date:  1971-02-08       Impact factor: 56.272

10.  Thrombocytosis in chronic inflammatory bowel disease.

Authors:  D A Morowitz; L W Allen; J B Kirsner
Journal:  Ann Intern Med       Date:  1968-05       Impact factor: 25.391
View more
  8 in total

Review 1.  Inflammatory bowel disease: perioperative pharmacological considerations.

Authors:  Ajay Kumar; Moises Auron; Ashish Aneja; Franziska Mohr; Alok Jain; Bo Shen
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

2.  Ischemic skin lesions in ulcerative colitis.

Authors:  H Chaun; J Day; W A Dodd; W L Dunn
Journal:  Can Med Assoc J       Date:  1985-04-15       Impact factor: 8.262

3.  Anti-cardiolipin antibodies in patients with inflammatory bowel disease.

Authors:  B W Aichbichler; W Petritsch; G A Reicht; H H Wenzl; A J Eherer; T A Hinterleitner; P Auer-Grumbach; G J Krejs
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

4.  Arterial thrombosis in ulcerative colitis. Transcatheter thrombolytic therapy.

Authors:  S J Lengle; P Nadler; G W Jordan
Journal:  West J Med       Date:  1995-06

5.  Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin.

Authors:  Anton A Vrij; Ardi Oberndorff-Klein-Woolthuis; Gerard Dijkstra; Andrea E de Jong; Rob Wagenvoord; Hendrik C Hemker; Reinhold W Stockbrügger
Journal:  J Thromb Thrombolysis       Date:  2007-02-17       Impact factor: 2.300

6.  Isolated cerebral thrombo-embolism and Crohn disease.

Authors:  S M Gormally; W Bourke; B Kierse; H Monaghan; J McMenamin; B Drumm
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

7.  Effects of low molecular weight heparin on platelet surface P-selectin expression and serum interleukin-8 production in rats with trinitrobenzene sulphonic acid-induced colitis.

Authors:  Bing Xia; Hong Han; Ke-Jian Zhang; Jin Li; Guang-Song Guo; Ling-Ling Gong; Xian-Chang Zeng; Jun-Yan Liu
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

8.  Takayasu's arteritis associated with idiopathic ulcerative colitis.

Authors:  V Sakhuja; K L Gupta; D K Bhasin; N Malik; K S Chugh
Journal:  Gut       Date:  1990-07       Impact factor: 23.059
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.